• QIAseq SARS-CoV-2 Primer Panel converts viral RNA samples into libraries ready for sequencing • QIAGEN Digital Insights solutions support COVID-19 drug, vaccine and epidemiology research Hilden, Germany, and Germantown, Maryland – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) launched the innovative QIAseq SARS-CoV-2 Primer Panel for next-generation sequencing (NGS) of the novel coronavirus genome, along with […]
Major platform advancements demonstrate applicability of biosimulation to accelerate drug discovery and development PRINCETON, NJ – Certara®, the global leader in biosimulation, today announced the development of a new biosimulation platform for COVID-19 vaccines and major enhancements in its Immunogenicity and Immuno-oncology QSP platforms. Certara has partnered with leading, global pharmaceutical companies on these advancements to […]
New solution to remove some of the current unknowns about the virus Boston & Lausanne, Switzerland: SOPHiA GENETICS, leader in Data-Driven Medicine, launches a first-of-its-kind multimodal solution to predict COVID-19 disease evolution, opening new dimensions of insight into the fight against the worldwide pandemic. This advancement goes beyond genomics, analyzing a wider spectrum of data […]
Combination of experts and software helps accelerate pediatric drug development and increase clinical trial success rates PRINCETON, NJ – Today, Certara®, the global leader in biosimulation, launches Certara Pediatrics, a new practice area to help biopharmaceutical companies apply model-informed drug development to their pediatric programs and better navigate the changing regulatory landscape. Certara Pediatrics brings together Certara’s […]
Merck KGaA, Darmstadt, Germany Selects Cambridge Semantics as Enterprise Data Fabric Provider Cambridge Semantics Aiding Merck KGaA, Darmstadt, Germany in Modernizing its Data Integration Capabilities and in Forging Multiple Data-driven Initiatives Business Wire BOSTON — Cambridge Semantics, the leading provider of modern, graph-driven data integration for the enterprise data fabric, today announced that Merck KGaA, […]
Cambridge, United Kingdom – Congenica, a digital health company enabling rapid analysis of complex genomic data, has launched an update for its clinical decision support platform that will provide automated classification, evidence and reporting of recurrent ‘known’ variants that customers observe in their rare disease cases, significantly saving time while maximizing diagnostic yield and laboratory throughput. The […]
Cambridge, United Kingdom – Congenica has launched Congenica Automation, an update for its clinical decision support platform that will provide automated classification, evidence and reporting of recurrent ‘known’ variants that customers observe in their rare disease cases, significantly saving time while maximizing diagnostic yield and laboratory throughput. The key to realizing the potential of precision medicine […]
Thermo Fisher Scientific–Genedata collaboration agreement enables direct integration of Thermo Fisher’s robotics and automation platforms with the Genedata Biopharma Platform, accelerating the discovery and development of next-generation biotherapeutics Basel, Switzerland – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a collaboration with Thermo Fisher Scientific, a leading international pharmaceutical and […]
Reduces genomic data storage and transfer costs associated with the data deluge In 2019, the volume of genomic data generated by Illumina’s global installed base of more than 15,000 sequencing systems increased more than 50 percent year-over-year, to 150 petabases. That is the equivalent of 500 years of continuous video recordings in high definition. This […]
Whole-genome sequencing offers the ability to reduce pediatric diagnostic odysseys which cost at least $14 billion annually in the U.S. SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) is bringing turn-key data analysis solutions to accelerate and facilitate the adoption of whole-genome sequencing with the launch of the TruSight™ Software Suite. TruSight Software delivers ready-made infrastructure to realize […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
